Do different metabolic syndrome definitions predict cerebrovascular events and coronary heart disease independent of their components?: 9 years follow-up of the tehran lipid and glucose study

Stroke

Volumn 43, Issue 6, 2012, Pages 1669-1671

  Hadaegh, Farzad ^a   Mohebi, Reza ^a   Cheraghi, Leila ^a   Tohidi, Maryam ^a   Moghaddam, Nahid Beladi ^a   Bozorogmanesh, Mohammadreza ^a   Sheikholeslami, Farhad ^a   Azizi, Fereidoun ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

coronary heart disease; hypertension; metabolic syndrome; stroke

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN; LIPID; TRIACYLGLYCEROL;

ARTICLE; BLOOD PRESSURE; CEREBROVASCULAR DISEASE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DYSLIPIDEMIA; EVALUATION AND FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; OBESITY; PREDICTIVE VALUE; PRIORITY JOURNAL; WAIST CIRCUMFERENCE;

AGED; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MODELS, BIOLOGICAL; MULTIVARIATE ANALYSIS; STROKE;

EID: 84861601523     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.112.650812     Document Type: Article

References (8)

1. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on epidemiology and prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120: 1640-1645.
2. Hadaegh F, Zabetian A, Khalili D, Safarkhani M, James WP, Azizi F. A new approach to compare the predictive power of metabolic syndrome defined by a Joint Interim Statement versus its components for incident cardiovascular disease in Middle East Caucasian residents in Tehran. J Epidemiol Community Health. Epub ahead of print November 4, 2010. DOI: jech.2010.117697.
3. Azizi F, Ghanbarian A, Momenan AA, Hadaegh F, Mirmiran P, Hedayati M, et al. Prevention of non-communicable disease in a population in nutrition transition: Tehran lipid and glucose study phase II. Trials. 2009;10:5.
4. Zabetian A, Hadaegh F, Azizi F. Prevalence of metabolic syndrome in Iranian adult population, concordance between the IDF with the ATPIII and the WHO definitions. Diabetes Res Clin Pract. 2007;77:251-257.
5. Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, et al. The metabolic syndrome and cardiovascular risk a systematic review and metaanalysis. J Am Coll Cardiol. 2010;56:1113-1132.
6. Gupta AK, Dahlof B, Sever PS, Poulter NR. Metabolic syndrome, independent of its components, is a risk factor for stroke and death but not for coronary heart disease among hypertensive patients in the ASCOT-BPLA. Diabetes Care. 2010;33:1647-1651.
7. Goldstein LB, Bushnell CD, Adams RJ, Appel LJ, Braun LT, Chaturvedi S, et al. Guidelines for the primary prevention of stroke: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:517-584.
8. Shahar E, Chambless LE, Rosamond WD, Boland LL, Ballantyne CM, McGovern PG, et al. Plasma lipid profile and incident ischemic stroke: the Atherosclerosis Risk In Communities (ARIC) study. Stroke. 2003;34: 623-631.